Quick-Med Technologies (QMDT) Stock Price

Quick-Med Technologies Price

NYSE·CLOSED
0.00USD+0.00 (+0.00 %)
Market closed

Revenue has compounded at 38.3% per year over the past 9 years to 928,500.00 USD. Quick-Med Technologies's net margin stands at -76.8%, up from -201.5% several years earlier. The stock trades about 700% above its 52-week low.

Quick-Med Technologies stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Quick-Med Technologies over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Quick-Med Technologies stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Quick-Med Technologies's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Quick-Med Technologies Stock Price History
DateQuick-Med Technologies Price
8/19/20260.00 USD
8/18/20260.00 USD
8/17/20260.00 USD
8/14/20260.00 USD
8/13/20260.00 USD
8/12/20260.00 USD
8/11/20260.00 USD
8/10/20260.00 USD
8/7/20260.00 USD
8/6/20260.00 USD
8/5/20260.00 USD
8/4/20260.00 USD
8/3/20260.00 USD
7/30/20260.00 USD
7/29/20260.00 USD
7/28/20260.00 USD
7/27/20260.00 USD
7/24/20260.00 USD
7/23/20260.00 USD
7/22/20260.00 USD
7/21/20260.00 USD
7/20/20260.00 USD
7/17/20260.00 USD
7/16/20260.00 USD
7/15/20260.00 USD
7/14/20260.00 USD
7/13/20260.00 USD
7/10/20260.00 USD
7/9/20260.00 USD
7/8/20260.00 USD
7/7/20260.00 USD
7/6/20260.00 USD
7/3/20260.00 USD
7/2/20260.00 USD
7/1/20260.00 USD
6/30/20260.00 USD
6/29/20260.00 USD
6/26/20260.00 USD
6/25/20260.00 USD
6/24/20260.00 USD
6/23/20260.00 USD
6/22/20260.00 USD
6/19/20260.00 USD
6/18/20260.00 USD
6/17/20260.00 USD
6/16/20260.00 USD
6/15/20260.00 USD
6/12/20260.00 USD
6/11/20260.00 USD
6/10/20260.00 USD
6/9/20260.00 USD
6/8/20260.00 USD
6/5/20260.00 USD
6/4/20260.00 USD
6/3/20260.00 USD
6/2/20260.00 USD
6/1/20260.00 USD
5/29/20260.00 USD
5/28/20260.00 USD
5/27/20260.00 USD
5/26/20260.00 USD
5/22/20260.00 USD
5/21/20260.00 USD
5/20/20260.00 USD
5/19/20260.00 USD
5/18/20260.00 USD
5/15/20260.00 USD
5/14/20260.00 USD
5/13/20260.00 USD
5/12/20260.00 USD
5/11/20260.00 USD
5/8/20260.00 USD
5/7/20260.00 USD
5/6/20260.00 USD
5/5/20260.00 USD
5/4/20260.00 USD
5/1/20260.00 USD
4/30/20260.00 USD
4/29/20260.00 USD
4/28/20260.00 USD
4/27/20260.00 USD
4/24/20260.00 USD
4/23/20260.00 USD
4/22/20260.00 USD
4/21/20260.00 USD
4/20/20260.00 USD
4/17/20260.00 USD
4/16/20260.00 USD
4/15/20260.00 USD
4/14/20260.00 USD
4/13/20260.00 USD
4/10/20260.00 USD
4/9/20260.00 USD
4/8/20260.00 USD
4/7/20260.00 USD
4/6/20260.00 USD
4/2/20260.00 USD
4/1/20260.00 USD
3/31/20260.00 USD
3/30/20260.00 USD
3/27/20260.00 USD
3/26/20260.00 USD
3/25/20260.00 USD
3/24/20260.00 USD
3/23/20260.00 USD
3/20/20260.00 USD
3/19/20260.00 USD
3/18/20260.00 USD
3/17/20260.00 USD
3/16/20260.00 USD
3/13/20260.00 USD
3/12/20260.00 USD
3/11/20260.00 USD
3/10/20260.00 USD
3/9/20260.00 USD
3/6/20260.00 USD
3/5/20260.00 USD
3/4/20260.00 USD
3/3/20260.00 USD
3/2/20260.00 USD
2/27/20260.00 USD
2/26/20260.00 USD
2/25/20260.00 USD
2/24/20260.00 USD
2/23/20260.00 USD
2/20/20260.00 USD
2/19/20260.00 USD
2/18/20260.00 USD
2/17/20260.00 USD
2/13/20260.00 USD
2/12/20260.00 USD
2/11/20260.00 USD
2/10/20260.00 USD
2/9/20260.00 USD
2/6/20260.00 USD
2/5/20260.00 USD
2/4/20260.00 USD
2/3/20260.00 USD
2/2/20260.00 USD
1/30/20260.00 USD
1/29/20260.00 USD
1/28/20260.00 USD
1/27/20260.00 USD
1/26/20260.00 USD
1/23/20260.00 USD
1/22/20260.00 USD
1/21/20260.00 USD
1/20/20260.00 USD
1/16/20260.00 USD
1/15/20260.00 USD
1/14/20260.00 USD
1/13/20260.00 USD
1/12/20260.00 USD
1/9/20260.00 USD
1/8/20260.00 USD
1/7/20260.00 USD
1/6/20260.00 USD
1/5/20260.00 USD
1/2/20260.00 USD
12/31/20250.00 USD
12/30/20250.00 USD
12/29/20250.00 USD
12/26/20250.00 USD
12/24/20250.00 USD
12/23/20250.00 USD
12/22/20250.00 USD
12/19/20250.00 USD
12/18/20250.00 USD
12/17/20250.00 USD
12/16/20250.00 USD
12/15/20250.00 USD
12/12/20250.00 USD
12/11/20250.00 USD
12/10/20250.00 USD
12/9/20250.00 USD
12/8/20250.00 USD
12/5/20250.00 USD
12/4/20250.00 USD
12/3/20250.00 USD
12/2/20250.00 USD
12/1/20250.00 USD
11/28/20250.00 USD
11/26/20250.00 USD
11/25/20250.00 USD
11/24/20250.00 USD
11/21/20250.00 USD
11/20/20250.00 USD
11/19/20250.00 USD
11/18/20250.00 USD
11/17/20250.00 USD
11/14/20250.00 USD
11/13/20250.00 USD
11/12/20250.00 USD
11/11/20250.00 USD
11/10/20250.00 USD
11/7/20250.00 USD
11/6/20250.00 USD
11/5/20250.00 USD
11/4/20250.00 USD
11/3/20250.00 USD
10/31/20250.00 USD
10/30/20250.00 USD
10/29/20250.00 USD
10/28/20250.00 USD
10/27/20250.00 USD
10/24/20250.00 USD
10/23/20250.00 USD
10/22/20250.00 USD
10/21/20250.00 USD
10/20/20250.00 USD
10/17/20250.00 USD
10/16/20250.00 USD
10/15/20250.00 USD
10/14/20250.00 USD
10/13/20250.00 USD
10/10/20250.00 USD
10/9/20250.00 USD
10/8/20250.00 USD
10/7/20250.00 USD
10/6/20250.00 USD
10/3/20250.00 USD
10/2/20250.00 USD
10/1/20250.00 USD
9/30/20250.00 USD
9/29/20250.00 USD
9/26/20250.00 USD
9/25/20250.00 USD
9/24/20250.00 USD
9/23/20250.00 USD
9/22/20250.00 USD
9/19/20250.00 USD
9/18/20250.00 USD
9/17/20250.00 USD
9/16/20250.00 USD
9/15/20250.00 USD
9/12/20250.00 USD
9/11/20250.00 USD
9/10/20250.00 USD
9/9/20250.00 USD
9/8/20250.00 USD
9/5/20250.00 USD
9/4/20250.00 USD
9/3/20250.00 USD
9/2/20250.00 USD
8/29/20250.00 USD
8/28/20250.00 USD
8/27/20250.00 USD
8/26/20250.00 USD
8/25/20250.00 USD
8/22/20250.00 USD
Access this data via the Eulerpool API
Get Free API Key

Quick-Med Technologies Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2006
1.23 M USD
-1.64 M USD
-1.70 M USD
Jan 1, 2007
1.95 M USD
-1.58 M USD
-1.50 M USD
Jan 1, 2008
1.36 M USD
-2.23 M USD
-2.39 M USD
Jan 1, 2009
1.00 M USD
-1.77 M USD
-2.02 M USD
Jan 1, 2010
993,900.00 USD
-2.09 M USD
-3.55 M USD
Jan 1, 2011
1.04 M USD
-2.05 M USD
-2.30 M USD
Jan 1, 2012
997,500.00 USD
-1.24 M USD
-1.69 M USD
Jan 1, 2013
928,500.00 USD
-376,100.00 USD
-713,100.00 USD

Quick-Med Technologies Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 22, 2026, 11:44 AM
 
REVENUEk USD
GROSS MARGIN%
GROSS INCOMEk USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
2004200520062007200820092010201120122013
––1,000.001,000.001,000.001,000.00–1,000.00––
––100.00100.00100.00100.00–100.00––
1,000.001,000.001,000.001,000.001,000.001,000.001,000.001,000.001,000.001,000.00
-2.00-1.00-1.00-1.00-2.00-1.00-2.00-2.00-1.00–
––-100.00-100.00-200.00-100.00–-200.00––
-2.00-1.00-1.00-1.00-2.00-2.00-3.00-2.00-1.00–
–-50.00––100.00–50.00-33.33-50.00–
23.2716.4130.0830.3630.7230.9431.2632.9537.3537.35
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Quick-Med Technologies generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Quick-Med Technologies retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Quick-Med Technologies's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Quick-Med Technologies has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Quick-Med Technologies's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Quick-Med Technologies stock margins

The Quick-Med Technologies margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Quick-Med Technologies. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Quick-Med Technologies.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2006
84.55 %
-133.33 %
-138.21 %
Jan 1, 2007
86.15 %
-81.03 %
-76.92 %
Jan 1, 2008
95.89 %
-163.48 %
-175.61 %
Jan 1, 2009
96.31 %
-175.80 %
-201.49 %
Jan 1, 2010
97.66 %
-209.78 %
-357.20 %
Jan 1, 2011
97.70 %
-197.36 %
-221.55 %
Jan 1, 2012
97.32 %
-124.14 %
-169.11 %
Jan 1, 2013
97.31 %
-40.51 %
-76.80 %

Quick-Med Technologies Stock Revenue, EBIT, Earnings per Share

The Quick-Med Technologies earnings per share therefore indicates how much revenue Quick-Med Technologies has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2006
0.04 USD
-0.05 USD
-0.06 USD
Jan 1, 2007
0.06 USD
-0.05 USD
-0.05 USD
Jan 1, 2008
0.04 USD
-0.07 USD
-0.08 USD
Jan 1, 2009
0.03 USD
-0.06 USD
-0.07 USD
Jan 1, 2010
0.03 USD
-0.07 USD
-0.11 USD
Jan 1, 2011
0.03 USD
-0.06 USD
-0.07 USD
Jan 1, 2012
0.03 USD
-0.03 USD
-0.05 USD
Jan 1, 2013
0.02 USD
-0.01 USD
-0.02 USD

Quick-Med Technologies business model & stock analysis

Quick-Med Technologies Inc is a US company based in Gainesville, Florida, specializing in medical technologies. The company was founded in 1994 by Dr. Robert Banas and Dr. John Kosinski to develop a solution to the increasing problem of multidrug-resistant bacteria in hospitals. Quick-Med Technologies' business model is based on the development and marketing of antimicrobial products for infection prevention. This includes wound dressings, textiles, and sprays equipped with a special technology to inhibit the growth of bacteria and fungi. The company works closely with customers in the healthcare, textile, and aviation industries to utilize its products in various applications. The growing demand for antimicrobial solutions and the increasing global threat of infections have made Quick-Med Technologies an important player in the market in recent years. The company specializes in four core areas: medical products, textiles, aviation, and veterinary medicine. In the medical products sector, Quick-Med Technologies offers innovative wound dressings with effective bacteriostatic properties. The dressings are well-tolerated and are particularly effective against multidrug-resistant bacteria. Additionally, there are special products for infection prevention, especially used in hospitals. The second sector, textiles, includes special anti-infection coating capabilities to equip textiles against mold, bacteria, and fungi. The company offers customers from the textile and apparel industry a variety of antimicrobial coated fabrics, which are also used in the hospitality, gastronomy, and public facilities sectors. These include bedding, towels, uniforms, and carpets, for example. In the aviation industry, antimicrobial coatings are used in aircraft cabins and other means of transportation to prevent infections. Quick-Med Technologies offers special disinfectants and sprays for effective cleaning and disinfection of surfaces. The company's fourth business area is veterinary medicine, where Quick-Med Technologies develops innovative solutions for disinfection and wound healing in animals. The company's products are used in both pet medicine and livestock farming and have proven to be effective against infections. Quick-Med Technologies has shown strong growth in recent years and has received a number of patents for its technology. The company also actively engages in research and development of new antimicrobial solutions and collaborates closely with industry and scientific partners. Overall, Quick-Med Technologies is an innovative company specializing in fighting infections and improving hygiene. The company's antimicrobial products help reduce the spread of bacteria and fungi in various applications, minimizing the risk of infections.

Quick-Med Technologies SWOT Analysis

Strengths

Quick-Med Technologies Inc has a strong portfolio of innovative and unique medical technologies that provide solutions for various healthcare challenges. Their products have been well-received in the market.

The company has a talented and experienced team of professionals who possess extensive knowledge and expertise in the medical field. This allows Quick-Med Technologies to stay at the forefront of scientific advancements and adapt to changing trends.

Weaknesses

Quick-Med Technologies Inc relies heavily on a limited number of products for their revenue generation. This high dependency poses a risk in case of any market fluctuations or decline in demand for their existing offerings.

The company faces stiff competition from other medical technology firms, which may have similar or alternative solutions. This puts pressure on Quick-Med Technologies to continuously innovate and differentiate themselves from competitors.

Opportunities

Quick-Med Technologies Inc can explore expansion into new geographic markets to tap into currently untapped customer segments. Additionally, they can identify and develop new products or enhancements to their existing offerings to meet the evolving needs of the healthcare industry.

The increasing demand for advanced medical technologies presents an opportunity for Quick-Med Technologies to grow their market share and increase their customer base. They can leverage their expertise to address emerging challenges and seize new possibilities.

Threats

Rapid technological advancements in the medical field may render Quick-Med Technologies' existing products obsolete if not updated or improved regularly. Thus, they need to stay vigilant and invest in research and development to remain competitive.

Regulatory changes and compliance requirements pose a threat to Quick-Med Technologies' operations. Any non-compliance issues can result in penalties and damage their reputation.

Quick-Med Technologies Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Quick-Med Technologies historical P/E ratio, EBIT multiple, and P/S ratio

Quick-Med Technologies annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Quick-Med Technologies shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2006
30.08 M Stocks
Jan 1, 2007
30.36 M Stocks
Jan 1, 2008
30.72 M Stocks
Jan 1, 2009
30.94 M Stocks
Jan 1, 2010
31.26 M Stocks
Jan 1, 2011
32.95 M Stocks
Jan 1, 2012
37.35 M Stocks
Jan 1, 2013
37.35 M Stocks
Price targets and forecasts for Quick-Med Technologies are not yet available.

Quick-Med Technologies Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
11/14/2011-0.01USD-276.87 MUSD-2012 Q1

Quick-Med Technologies shareholder structure

% Name
0.00000%
Cullinan Associates, Inc.
Cullinan Associates, Inc.

Quick-Med Technologies Executives and Management Board

5 members · avg. age 60 · 0 % women

BL

Dr. Bernd Liesenfeld (43)

President, Director · since 2012

126,125.00 USD

Management

PJ

Paul Jenssen (57)

Chief Financial Officer, Director · since 2013

80,338.00 USD

Board of Directors

GO

Gerald Olderman (79)

Director · since 1997

127,275.00 USD
GS

Dr. Gregory Schultz (63)

Chairman of the Board · since 2000

–
DB

Dale Bergman (57)

Independent Director

–

Quick-Med Technologies Supply Chain

Frequently asked questions about Quick-Med Technologies

The business model of Quick-Med Technologies Inc. focuses on developing and commercializing advanced technologies for infection prevention and control. Quick-Med Technologies Inc. utilizes its proprietary antimicrobial technology to create innovative products that prevent and treat infections. The company's solutions are based on a patented platform technology called NIMBUS®, which is effective against a broad spectrum of microorganisms, including bacteria, viruses, fungi, and other pathogens. Quick-Med Technologies Inc. leverages its expertise in medical-grade antimicrobial technology to provide healthcare professionals and consumers with effective, safe, and cost-efficient infection prevention solutions.

Quick-Med Technologies Inc is primarily active in the healthcare and medical industries.

The main competitors of Quick-Med Technologies Inc in the market include companies such as Johnson & Johnson, 3M Company, and Smith & Nephew plc. These companies also operate in the healthcare and medical technology sectors, offering similar products and services. However, Quick-Med Technologies Inc aims to differentiate itself through its innovative solutions and technologies, providing competitive advantages in the market.

Quick-Med Technologies Inc, a leading biotechnology company, has a rich history and background. Established in [insert year], Quick-Med Technologies Inc has quickly emerged as a pioneer in the field of innovative healthcare solutions. With a focus on developing advanced products for wound care and infection prevention, Quick-Med Technologies Inc has become synonymous with cutting-edge technology and superior quality. The company's unwavering commitment to research and development has led to groundbreaking breakthroughs, enabling it to revolutionize the medical industry. Quick-Med Technologies Inc continues to push boundaries and deliver remarkable solutions, cementing its position as a global leader in the biotechnology sector.

Quick-Med Technologies Inc has achieved several significant milestones. The company successfully developed and commercialized its proprietary antimicrobial technology, which has gained widespread recognition in the healthcare industry. Quick-Med Technologies Inc also secured multiple patents to protect its innovative products and processes. With a strong focus on research and development, the company has made remarkable advancements in the field of antimicrobial technology. Quick-Med Technologies Inc has garnered recognition from various prestigious organizations, including the Wall Street Journal, and continues to strive for excellence in improving infection control measures through its groundbreaking solutions.

Quick-Med Technologies Inc is primarily present in the United States.

Quick-Med Technologies Inc represents a strong commitment to innovation and medical advancements. The company is dedicated to developing cutting-edge technologies in the field of healthcare, aiming to improve patients' lives worldwide. With a focus on research and development, Quick-Med Technologies Inc strives to create effective and safe solutions that address critical medical needs. The company's corporate philosophy is centered around integrity, collaboration, and excellence, aiming to deliver impressive results that positively impact the healthcare industry. Quick-Med Technologies Inc's dedication to advancing medical technologies showcases its commitment to driving progress and making a meaningful difference in the lives of patients and healthcare professionals.

Converted at the current exchange rate, the Quick-Med Technologies share trades at 0.00 EUR (0.00 USD).

Quick-Med Technologies Inc is a company that focuses on the manufacturing and marketing of high-tech technologies that contribute to improving healthcare. The company is based in Gainesville, Florida and has been in the market since 1994. Quick-Med's business model is based on offering innovative technologies that contribute to creating a better world, as well as developing and marketing proprietary products. The company operates in various areas including infection control, wound management, bioactivity, and women's health. One important area that the company operates in is infection control. Quick-Med offers a wide range of antimicrobial technologies and products that help prevent the spread of infections and improve hygiene conditions in various settings. An example is the patient contact antimicrobial dressing, which helps prevent infections from catheters and other medical devices. Another area that Quick-Med operates in is wound management. The company offers a range of products that help wounds heal faster and prevent infections. These include hydrogel dressings, silicone dressings, and other advanced products that help reduce the risk of complications in wound care. Quick-Med is also involved in the field of bioactivity. The company has developed groundbreaking technologies that stimulate biological processes in the body and improve health. These include technologies that support wound healing and technologies that promote bone and tissue regeneration. Another important area that Quick-Med operates in is women's health. The company offers advanced products that help improve women's health. These include technologies that assist in pregnancy prevention and products that contribute to better quality of life for women during menopause. In addition to its various divisions, Quick-Med also provides a range of services. For example, the company offers customized solutions tailored to the needs of its customers. Additionally, the company offers support in product development and clinical trial execution. In summary, Quick-Med Technologies Inc is a company specialized in the development of innovative technologies that help improve the health and well-being of people around the world. Quick-Med operates in various areas including infection control, wound management, bioactivity, and women's health. The company offers a wide range of products and services to meet the needs of its customers.

The revenue cannot currently be calculated for Quick-Med Technologies.

The profit cannot currently be calculated for Quick-Med Technologies.

The P/E ratio cannot be calculated for Quick-Med Technologies at the moment.

The P/S cannot be calculated for Quick-Med Technologies currently.

The Eulerpool Quality Score for Quick-Med Technologies is 2/10.

The ISIN of Quick-Med Technologies is US74837Q1067. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Quick-Med Technologies is 213757. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Quick-Med Technologies is QMDT. The ticker symbol is used to trade Quick-Med Technologies shares on the stock exchange.

Quick-Med Technologies paid dividends every year for the past 0 years.

Quick-Med Technologies is assigned to the 'Health' sector.

The dividends of Quick-Med Technologies are distributed in USD.

All fundamentals and in-depth analysis of Quick-Med Technologies

Our stock analysis for Quick-Med Technologies stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Quick-Med Technologies. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Quick-Med Technologies Stock
Quick-Med Technologies Revenue→
Quick-Med Technologies Stock
Quick-Med Technologies Net Income→
Quick-Med Technologies Stock
Quick-Med Technologies P/E→
Quick-Med Technologies Stock
Quick-Med Technologies P/S→
Quick-Med Technologies Stock
Quick-Med Technologies EBIT→
Quick-Med Technologies Stock
Quick-Med Technologies Dividend→
Quick-Med Technologies Stock
Quick-Med Technologies Directors Dealings→
Quick-Med Technologies Stock
Quick-Med Technologies Stocks→
Quick-Med Technologies Stock
Quick-Med Technologies Market capitalization→
Quick-Med Technologies Stock
Quick-Med Technologies Debt→
Quick-Med Technologies Stock
Quick-Med Technologies Liabilities→
Quick-Med Technologies Stock
Quick-Med Technologies Equity→
Quick-Med Technologies Stock
Quick-Med Technologies AAQS→
Quick-Med Technologies Stock
Quick-Med Technologies Employees→
Quick-Med Technologies Stock
Quick-Med Technologies ROE→
Quick-Med Technologies Stock
Quick-Med Technologies ROA→
Quick-Med Technologies Stock
Quick-Med Technologies ROCE→
Quick-Med Technologies Stock
Quick-Med Technologies News→
Quick-Med Technologies Stock
Quick-Med Technologies Analyst Price Targets→

Health Stocks

QuidelQuest PharmatechQuince TherapeuticsQuest LaboratoriesQuoin Pharmaceuticals Ltd DRCQuest DiagnosticsQuratisQuantum-SiQurient CoQuantum Medical TransportR&G PharmaStudies CoQuantum HealthcareAll Stocks A–Z →